Back
HFA Premium Access

Discovery and characterization of a long-acting relaxin analog, LY3540378, for the treatment of chronic heart failure

Session: Heart Failure ePosters - focus on Basic Science
Topic: Drugs, Drug Targets
Speaker: Doctor X. Wang (Indianapolis, US)
Event: Heart Failure 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Xiaojun Wang

Eli Lilly & Co, Indianapolis (United States of America)
3 followers

23 more presentations in this session

Characterization of right ventricular alterations induced by long-term intense exercise training in a rat model of athletes heart

Speaker: Doctor A. Olah (Budapest, HU)

Access
Abstract
Slides
Like
Thumbnail

Psychomotor performance is relevant determinant of cardiopulmonary capacity

Speaker: Doctor R. Skalik (Wroclaw, PL)

Access
Abstract
Slides
Like
Thumbnail

Comparison of systemic inflammation activity and patients immune status in patients with different forms of atrial fibrillation and flutter and heart failure

Speaker: Doctor O. Marchenko (Kyiv, UA)

Access
Abstract
Slides
Like
Thumbnail

Inflammation markers as predictors of mortality in hospitalized patients infected with the SARS-COV-2

Speaker: Mr J. Aguilar-Meza (Mexico City, MX)

Access
Abstract
Slides
Like
Thumbnail

Cardiac fibroblasts as central players in sex- and age-related differences in cardiac fibrosis and inflammation

Speaker: Doctor K. Pappritz (Berlin, DE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Heart Failure ePosters - focus on Basic Science

Speakers: Doctor X. Wang, Doctor A. Olah, Doctor R. Skalik, Doctor O. Marchenko, Mr J. Aguilar-Meza...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources